Insulet (PODD) EPS (Diluted) Growth (3y) (2019 - 2026)
Insulet (PODD) EPS (Diluted) Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 18.07% |
| 10 | Insulet | 10.31 Bn | 9.78 Bn | 562.60 Mn | 52.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.07% |
| Mar 31, 2026 | 56.35% |
| Dec 31, 2025 | 79.85% |
| Sep 30, 2025 | 164.72% |
| Jun 30, 2025 | 38.05% |
| Mar 31, 2025 | 6.37% |
| Dec 31, 2024 | 47.37% |
| Sep 30, 2024 | 79.57% |
| Jun 30, 2024 | 106.59% |
| Dec 31, 2023 | 95.01% |
| Sep 30, 2023 | 59.54% |
| Jun 30, 2023 | 21.02% |
| Mar 31, 2023 | 130.00% |
| Dec 31, 2022 | 44.71% |
| Sep 30, 2022 | -98.63% |
| Jun 30, 2022 | -189.10% |
| Mar 31, 2022 | 76.84% |
| Dec 31, 2021 | 37.92% |
| Sep 30, 2021 | 88.24% |
| Jun 30, 2021 | -135.38% |